Adagene Inc. Competitors
Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|---|
ACRV
|
Acrivon Therapeutics, Inc. Common Stock | $7.76 | $223.86 M | -2.51 | 58 | $0 |
ANAB
|
AnaptysBio, Inc. | $19.46 | $640.07 M | -3.82 | 117 | $17.16 M |
ANEB
|
Anebulo Pharmaceuticals, Inc. | $1.88 | $56.28 M | -5.86 | 2 | $0 |
ANTX
|
AN2 Therapeutics, Inc. | $1.10 | $60.55 M | -0.81 | 41 | $0 |
AVTE
|
Aerovate Therapeutics, Inc. | $2.67 | $597.48 M | -6.84 | 51 | $0 |
ELYM
|
Eliem Therapeutics, Inc. | $5.11 | $258.33 M | -17.08 | 9 | $0 |
JANX
|
Janux Therapeutics, Inc. | $55.39 | $2.29 B | -36.8 | 69 | $8.08 M |
MLYS
|
Mineralys Therapeutics, Inc. | $13.70 | $652.38 M | -6.03 | 28 | $0 |
MOLN
|
Molecular Partners AG | $5.82 | $135.05 M | -2.03 | 167 | $7.04 M |
PMVP
|
PMV Pharmaceuticals, Inc. | $1.66 | $85.40 M | -1.26 | 63 | $0 |
RZLT
|
Rezolute, Inc. | $5.44 | $229.57 M | -5.02 | 51 | $0 |